Back to top

Genomic Health, Inc. Enters Oversold Territory

Read MoreHide Full Article

Genomic Health, Inc.’s (GHDX - Free Report) share price has entered into oversold territory with a stochastic value of 11.3322. The Zacks Consensus Estimate on the company’s earnings for year ending December 2012 increased by 2 cents over the past month to 18 cents per share. Genomic Health, Inc. is a Zacks #2 Rank (“Buy”) company.


In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Genomic Health, Inc. (GHDX) - free report >>

More from Zacks Tale of the Tape

You May Like